EUVIMEDEUVIMED entdecken
Crossref

Rapid LC-MS/MS-based quantitative serum tryptophan metabolomics platform identifies and monitors novel biomarkers for diabetic kidney disease

Lingshuai Zeng, Juan Bai, Xinrong Zou, Yi Zheng, Guangzhong Liu, Rui Lin, Yu Zhao, Xue Xue, Xiaoqin Wang

Analytical and Bioanalytical Chemistry · 2026-01 · 418 (1) · 285-297

DOI: 10.1007/s00216-025-06221-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Analytical and Bioanalytical Chemistry, online erschienen am 11.11.2025. Verfasst von Lingshuai Zeng und 8 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Laboratory, Hubei Provincial Hospital of Traditional Chinese Medicine, Affiliated Hospital of Hubei University of Chinese Medicine, Hubei Pr…. Hauptthemen laut MEDLINE: Tryptophan, Tandem Mass Spectrometry, Metabolomics, Diabetic Nephropathies. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 69 Literaturangaben. Gefördert von: Project of Hubei Administration of Traditional Chinese Medicine, National Natural Science Foundation of China, Natural Science Foundation of Hubei Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetic kidney disease (DKD) is a leading cause of end-stage kidney disease worldwide. Conventional diagnostic tools lack sufficient sensitivity, necessitating novel biomarkers and reliable analytical platforms to improve DKD management. In this study, a serum tryptophan (TRP) metabolomics platform based on liquid chromatography-tandem mass spectrometry (LC-MS/MS) was developed. After analytical optimization and validation, this platform was applied to a hospital-based case-control study (n = 200) for DKD. Associations between TRP metabolites and DKD risk were investigated via multivariable logistic regression. Metabolites demonstrating independent associations underwent diagnostic evaluation using receiver operating characteristic analysis with bootstrap internal validation. This LC-MS/MS platform enabled rapid quantification for TRP and 18 related metabolites within 6 min with low limits of detection, satisfactory recoveries, and acceptable matrix effects, meeting stringent analytical criteria suitable for clinical application. Seven TRP metabolites were significantly associated with DKD after covariate adjustment: 3-hydroxykynurenine (3-HK), 5-hydroxyindole acetic acid, indole-3-acetamide, and indole exhibited positive associations, while 3-hydroxyanthranilic acid, 5-hydroxytryptophan, and xanthurenic acid (XA) showed inverse associations. Individual metabolites demonstrated promising diagnostic performance (AUCs 0.762-0.896, sensitivities 65-80%, specificities 63-91%), except indole (AUC 0.683, sensitivity 51%, specificity 85%). Critically, the biomarker panel combining 3-HK and XA achieved exceptional diagnostic accuracy (AUC 0.970, sensitivity 92%, specificity 98%) for DKD. Bootstrap internal validation confirmed the stability of these findings. This study provided an LC-MS/MS-based platform for serum TRP metabolomics and identified a biomarker panel with exceptional diagnostic accuracy for DKD, offering significant potential as a clinically feasible tool for improving the diagnosis and management of DKD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TryptophanTandem Mass SpectrometryMetabolomicsDiabetic NephropathiesHumansBiomarkersMaleChromatography, LiquidMiddle AgedFemaleCase-Control StudiesAgedAdultLimit of DetectionLiquid Chromatography-Mass Spectrometry

Stichwörter der Autor:innen

BiomarkerDiabetic kidney diseaseDiagnosisLiquid chromatography-tandem mass spectrometryMetabolomicsTryptophan metabolism

Substanzen

TryptophanBiomarkers

Autor:innen und Institutionen

  • Clinical Laboratory, Hubei Provincial Hospital of Traditional Chinese Medicine, Affiliated Hospital of Hubei University of Chinese Medicine, Hubei Provincial Institute of Traditional Chinese Medicine, Wuhan, 430074, Hub…
  • School of Traditional Chinese Medicine, Hubei University of Chinese Medicine, Wuhan, 430000, Hubei, China.
  • Department of Nephrology, Hubei Key Laboratory of Theory and Application Research of Liver and Kidney in Traditional Chinese Medicine, Hubei Provincial Hospital of Traditional Chinese Medicine, Wuhan, 430061, Hubei, Chi…
  • Affiliated Hospital of Hubei University of Chinese Medicine, Shizhen Laboratory, Hubei Provincial Hospital of Traditional Chinese Medicine, Wuhan, 430061, Hubei, China. xue025004138@163.com.

Förderung

  • Project of Hubei Administration of Traditional Chinese Medicine
  • National Natural Science Foundation of China
  • Natural Science Foundation of Hubei Province
  • Project of State Administration of Traditional Chinese Medicine of China

Zitieren

APA

Zeng, L., Bai, J., Zou, X., Zheng, Y., Liu, G., Lin, R., Zhao, Y., Xue, X., & Wang, X. (2026). Rapid LC-MS/MS-based quantitative serum tryptophan metabolomics platform identifies and monitors novel biomarkers for diabetic kidney disease. Analytical and Bioanalytical Chemistry, 418(1), 285-297. https://doi.org/10.1007/s00216-025-06221-3

Vancouver

Zeng L, Bai J, Zou X, Zheng Y, Liu G, Lin R, et al. Rapid LC-MS/MS-based quantitative serum tryptophan metabolomics platform identifies and monitors novel biomarkers for diabetic kidney disease. Analytical and Bioanalytical Chemistry. 2026;418(1):285-297. doi:10.1007/s00216-025-06221-3

BibTeX
@article{Zeng2026,
  author = {Zeng, Lingshuai and Bai, Juan and Zou, Xinrong and Zheng, Yi and Liu, Guangzhong and Lin, Rui and Zhao, Yu and Xue, Xue and Wang, Xiaoqin},
  title = {Rapid LC-MS/MS-based quantitative serum tryptophan metabolomics platform identifies and monitors novel biomarkers for diabetic kidney disease},
  journal = {Analytical and Bioanalytical Chemistry},
  year = {2026},
  volume = {418},
  number = {1},
  pages = {285--297},
  doi = {10.1007/s00216-025-06221-3}
}
Kostenlos starten →